Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patients

Arthritis and Rheumatism
Camillo RibiFrench Vasculitis Study Group

Abstract

To assess the efficacy of systemic corticosteroids alone as first-line treatment of polyarteritis nodosa (PAN) and microscopic polyangiitis (MPA) without poor-prognosis factors as defined by the Five-Factors Score (FFS), and to compare the efficacy and safety of azathioprine versus pulse cyclophosphamide as adjunctive immunosuppressive therapy for patients experiencing treatment failure or relapse. This prospective, multicenter, therapeutic trial included 124 patients with newly diagnosed PAN or MPA (FFS of 0) treated with corticosteroids alone. At the time of treatment failure or disease relapse, patients were randomized to receive 6 months of therapy with oral azathioprine or 6 pulses of cyclophosphamide. Analyses was performed according to an intent-to-treat strategy. The mean +/- SD followup period was 62 +/- 33 months. Treatment with corticosteroids alone induced remission in 98 patients; 50 (40%) of these patients had sustained disease remission, 46 (37%) experienced a relapse, and 2 became corticosteroid dependent (daily prednisone dose > or = 20 mg). In 26 patients (21%), treatment with corticosteroids alone failed, and 49 patients (40%) required additional immunosuppression. Among the 39 patients randomized, 13 of 19 a...Continue Reading

References

Aug 2, 1979·The New England Journal of Medicine·A S FauciS M Wolff
Dec 1, 1979·The American Journal of Medicine·E S LeibH E Paulus
Oct 1, 1991·Kidney International·C D PuseyC M Lockwood
Feb 1, 1990·The New England Journal of Medicine·H YaziciG E Lovatt
Feb 1, 1994·Arthritis and Rheumatism·J C JennetteC G Kallenberg
Mar 24, 1999·Arthritis and Rheumatism·L GuillevinB Jarrousse
Oct 10, 2002·Kidney International·Herbert A HauerUNKNOWN European Vasculitis Study Group (EUVAS)
Apr 8, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sven WeidnerHarald D Rupprecht
Jun 22, 2007·Journal of the American Society of Nephrology : JASN·David R W JayneUNKNOWN European Vasculitis Study Group
Dec 1, 2007·Arthritis and Rheumatism·Olivier FainLoïc Guillevin

❮ Previous
Next ❯

Citations

Feb 4, 2014·Journal of Autoimmunity·José Hernández-RodríguezMaria C Cid
Feb 1, 2011·Therapeutic Advances in Musculoskeletal Disease·Tanaz A KermaniShreyasee Amin
Nov 18, 2014·Rheumatic Diseases Clinics of North America·Lindsy Forbess, Serguei Bannykh
Jan 3, 2014·The New England Journal of Medicine·Russell GoodmanJoseph Loscalzo
Jun 14, 2014·Current Rheumatology Reports·Loïc Guillevin
Nov 14, 2014·Zeitschrift für Rheumatologie·J H SchirmerF Moosig
Sep 11, 2013·Clinical and Experimental Nephrology·Loïc Guillevin
Apr 22, 2016·Journal of Nephrology·Federica MaritatiAugusto Vaglio
Apr 27, 2016·Pediatric Rheumatology Online Journal·Despina Eleftheriou, Paul A Brogan
Mar 27, 2013·European Journal of Internal Medicine·Tobias BrummaierHerwig Pieringer
Apr 28, 2017·Nature Reviews. Neurology·Michael P Collins, Robert D Hadden
Dec 19, 2016·International Journal of Rheumatic Diseases·Aman SharmaSurjit Singh
Apr 12, 2017·Best Practice & Research. Clinical Gastroenterology·Matthew J Koster, Kenneth J Warrington
Apr 2, 2015·Therapeutic Advances in Musculoskeletal Disease·Franz Blaes
Dec 6, 2017·Zeitschrift für Rheumatologie·Jan Henrik SchirmerFrank Moosig
Jun 20, 2017·International Journal of Rheumatic Diseases·Abdulsamet ErdenSeza Özen
Sep 25, 2015·The Cochrane Database of Systematic Reviews·Giles WaltersJonathan C Craig
Sep 13, 2017·Clinical Reviews in Allergy & Immunology·Francesco MuratoreCarlo Salvarani
Nov 3, 2015·The Journal of Rheumatology·Lucy McGeochUNKNOWN Canadian Vasculitis Research Network
Aug 16, 2019·Expert Review of Clinical Immunology·Christian Pagnoux, Arielle Mendel
Sep 28, 2017·Arthritis & Rheumatology·Xavier PuéchalUNKNOWN French Vasculitis Study Group
Apr 16, 2020·Expert Opinion on Biological Therapy·Loïc Raffray, Loïc Guillevin
Sep 16, 2011·Current Opinion in Ophthalmology·Jean SchmidtEric L Matteson
Jan 30, 2015·European Journal of Clinical Investigation·Andreas KronbichlerGert Mayer
May 29, 2018·Zeitschrift für Rheumatologie·Jan H Schirmer, Frank Moosig
Jan 26, 2016·The Australasian Journal of Dermatology·Janet Kim, Jonathan J Chan
Jan 14, 2020·The Cochrane Database of Systematic Reviews·Giles D WaltersJonathan C Craig
Dec 1, 2013·Auto- Immunity Highlights·Petra M PegoJoão Matos Costa
Dec 7, 2018·The International Journal of Lower Extremity Wounds·Eran ShavitR Gary Sibbald
May 21, 2019·Frontiers in Neurology·Shanshan ZhangGe Tan
Mar 16, 2019·Frontiers in Immunology·Yuting JiangXuefeng Wang
May 18, 2019·Current Gastroenterology Reports·Ari Garber, Miguel Regueiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.